× Industry Reports Services Press Release Contact us About us

North America In-vitro Diagnostics Market Size By Product Type (Reagents & Kits, Instruments), By Service Type (Data Management Software, Services), By Technology (Clinical Chemistry, Immunoassay/Immunochemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Haemostasis, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/ Pharmacogenomics) By End-User (Hospitals, Point-Of-Care Testing, Laboratories, Academic Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada), Application Potential, Competitive Market Share & Forecast, 2018 – 2024

Published Date: August 2018 | Publisher: Graphical Research Report ID: GR1033 | Delivery : PDF

Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1.  Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2.  Primary

Chapter 2. Executive Summary

2.1. North America in-vitro diagnostics  industry 3600 synopsis, 2013 - 2024

2.1.1.  Business trends

2.1.2.  Product type trends

2.1.3.  Service type trends

2.1.4.  Technology trends

2.1.5.  Application trends

2.1.6.  End-user trends

2.1.7.  Regional trends

Chapter 3. North America In-vitro Diagnostics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1.  Growing rate of healthcare infections

3.3.1.2.  Surging number of pathology labs and services equipped with advanced diagnostic machines

3.3.1.3.  Increasing awareness regarding viral disease detection in the U.S.

3.3.2.  Industry pitfalls and challenges

3.3.2.1.  Excessive costs of the diagnostic services

3.4. Growth potential analysis

3.4.1.  By product type

3.4.2.  By service type

3.4.3.  By technology

3.4.4.  By application

3.4.5.  By end-user

3.5. Regulatory landscape

3.5.1.  U.S.

3.6. Porter’s analysis

3.7. Competitive landscape, 2017

3.7.1.  Strategy dashboard

3.8. PESTEL analysis

Chapter 4. North America In-vitro Diagnostics Market, By Product Type

4.1. Key segment trends

4.2. Reagents & kits

4.2.1.  Market size, by country, 2013-2024 (USD Million)

4.3. Instruments

4.3.1.  Market size, by country, 2013-2024 (USD Million)

Chapter 5. North America In-vitro Diagnostics Market, By Service Type

5.1. Key segment trends

5.2. Data management software

5.2.1.  Market size, by country, 2013-2024 (USD Million)

5.3. Services

5.3.1.  Market size, by country, 2013-2024 (USD Million)

Chapter 6. North America In-Vitro Diagnostics  Market, By Technology

6.1. Key segment trend

6.2. Clinical chemistry

6.2.1.  Market size, by country, 2013-2024 (USD Million)

6.3. Immunoassay/immunochemistry

6.3.1.  Market size, by country, 2013-2024 (USD Million)

6.4. Molecular diagnostics

6.4.1.  Market size, by country, 2013-2024 (USD Million)

6.5. Hematology

6.5.1.  Market size, by country, 2013-2024 (USD Million)

6.6. Microbiology

6.6.1.  Market size, by country, 2013-2024 (USD Million)

6.7. Coagulation and hemostasis

6.7.1.  Market size, by country, 2013-2024 (USD Million)

6.8. Urinalysis

6.8.1.  Market size, by country, 2013-2024 (USD Million)

6.9. Others

6.9.1.  Market size, by country, 2013-2024 (USD Million)

Chapter 7. North America In-vitro Diagnostics Market, By Application

7.1. Key segment trend

7.2. Oncology

7.2.1.  Market size, by country, 2013-2024 (USD Million)

7.3. Infectious diseases

7.3.1.  Market size, by country, 2013-2024 (USD Million)

7.4. Diabetes

7.4.1.  Market size, by country, 2013-2024 (USD Million)

7.5. Cardiology

7.5.1.  Market size, by country, 2013-2024 (USD Million)

7.6. Nephrology

7.6.1.  Market size, by country, 2013-2024 (USD Million)

7.7. Autoimmune diseases

7.7.1.  Market size, by country, 2013-2024 (USD Million)

7.8. Drug testing/pharmacogenomics

7.8.1.  Market size, by country, 2013-2024 (USD Million)

7.9. Others

7.9.1.  Market size, by country, 2013-2024 (USD Million)

Chapter 8. North America In-vitro Diagnostics Market, By End-User

8.1. Key segment trend

8.2. Hospitals

8.2.1.  Market size, by country, 2013-2024 (USD Million)

8.3. Point of care

8.3.1.  Market size, by country, 2013-2024 (USD Million)

8.4. Laboratories

8.4.1.  Market size, by country, 2013-2024 (USD Million)

8.5. Academic institutes

8.5.1.  Market size, by country, 2013-2024 (USD Million)

8.6. Others

8.6.1.  Market size, by country, 2013-2024 (USD Million)

Chapter 9. North America In-vitro Diagnostics Market, By Region

9.1. Key regional market

9.2. North America

9.2.1.  Market size, by country, 2013 - 2024(USD Million)

9.2.2.  Market size, by product type, 2013 - 2024(USD Million)

9.2.3.  Market size, by service type, 2013 - 2024(USD Million)

9.2.4.  Market size, by technology, 2013 - 2024(USD Million)

9.2.5.  Market size, by application, 2013 - 2024(USD Million)

9.2.6.  Market size, by end-user, 2013 - 2024(USD Million)

9.2.7.  U.S.

9.2.7.1.    Market size, by product type, 2013 - 2024(USD Million)

9.2.7.2.    Market size, by service type, 2013 - 2024(USD Million)

9.2.7.3.    Market size, by technology, 2013 - 2024(USD Million)

9.2.7.4.    Market size, by application, 2013 - 2024(USD Million)

9.2.7.5.    Market size, by end-user, 2013 - 2024(USD Million)

9.2.8.  Canada

9.2.8.1.    Market size, by product type, 2013 - 2024(USD Million)

9.2.8.2.    Market size, by service type, 2013 - 2024(USD Million)

9.2.8.3.    Market size, by technology, 2013 - 2024(USD Million)

9.2.8.4.    Market size, by application, 2013 - 2024(USD Million)

9.2.8.5.    Market size, by end-user, 2013 - 2024(USD Million)

Chapter 10.  Company Profiles

10.1.   Abbott

10.1.1. Business overview

10.1.2.   Financial data

10.1.3.   Product landscape

10.1.4.   Strategic outlook

10.1.5.   SWOT analysis

10.2.   Becton Dickinson

10.2.1. Business overview

10.2.2.   Financial data

10.2.3.   Product landscape

10.2.4.   Strategic outlook

10.2.5.   SWOT analysis

10.3.   BioRad

10.3.1. Business overview

10.3.2.   Financial data

10.3.3.   Product landscape

10.3.4.   Strategic outlook

10.3.5.   SWOT analysis

10.4.   BioMerieux

10.4.1. Business overview

10.4.2.   Financial data

10.4.3.   Product landscape

10.4.4.   Strategic outlook

10.4.5.   SWOT analysis

10.5.   Cephied

10.5.1. Business overview

10.5.2.   Financial data

10.5.3.   Product landscape

10.5.4.   Strategic outlook

10.5.5.   SWOT analysis

10.6.   Danaher

10.6.1. Business overview

10.6.2.   Financial data

10.6.3.   Product landscape

10.6.4.   Strategic outlook

10.6.5.   SWOT analysis

10.7.   Grifols

10.7.1. Business overview

10.7.2.   Financial data

10.7.3.   Product landscape

10.7.4.   Strategic outlook

10.7.5.   SWOT analysis

10.8.   Johnson & Johnson

10.8.1. Business overview

10.8.2.   Financial data

10.8.3.   Product landscape

10.8.4.   Strategic outlook

10.8.5.   SWOT analysis

10.9.   Luminex

10.9.1. Business overview

10.9.2.   Financial data

10.9.3.   Product landscape

10.9.4.   Strategic outlook

10.9.5.   SWOT analysis

10.10. Roche Diagnostics

1.1.1.   Business overview

1.1.2.  Financial data

1.1.3.  Product landscape

1.1.4.  Strategic outlook

10.10.1.  SWOT analysis

10.11. Siemens

1.1.5.   Business overview

1.1.6.  Financial data

1.1.7.  Product landscape

1.1.8.  Strategic outlook

1.1.9.  SWOT analysis

10.12. Sorin

1.1.10. Business overview

1.1.11.   Financial data

1.1.12.   Product landscape

1.1.13.   Strategic outlook

1.1.14.   SWOT analysis

10.13. Thermo Fisher

1.1.15.  Business overview

1.1.16.   Financial data

1.1.17.   Product landscape

1.1.18.   Strategic outlook

SWOT analysis

10.14. Qiagen

1.1.19. Business overview

1.1.20.   Financial data

1.1.21.   Product landscape

1.1.22.   Strategic outlook

1.1.23.   SWOT analysis

 

Data Tables

TABLE 1.    North America in-vitro diagnostics industry 360 0 synopsis, 2013 – 2024

TABLE 2.    North America in-vitro diagnostics market, 2013-2017 (USD Million)

TABLE 3.    North America in-vitro diagnostics market, 2018-2024 (USD Million)

TABLE 4.    North America in-vitro diagnostics market, by product type, 2013-2017 (USD Million)

TABLE 5.    North America in-vitro diagnostics market, by product type, 2018-2024 (USD Million)

TABLE 6.    North America in-vitro diagnostics market, by service type, 2013-2017 (USD Million)

TABLE 7.    North America in-vitro diagnostics market, by service type, 2018-2024 (USD Million)

TABLE 8.    North America in-vitro diagnostics market, by technology, 2013-2017 (USD Million)

TABLE 9.    North America in-vitro diagnostics market, by technology, 2018-2024 (USD Million)

TABLE 10.    North America in-vitro diagnostics market, by application, 2013-2017 (USD Million)

TABLE 11.    North America in-vitro diagnostics market, by application, 2018-2024 (USD Million)

TABLE 12.    North America in-vitro diagnostics market, by end-user, 2013-2017 (USD Million)

TABLE 13.    North America in-vitro diagnostics market, by end-user, 2018-2024 (USD Million)

TABLE 14.    North America in-vitro diagnostics market, by country, 2013-2017 (USD Million)

TABLE 15.    North America in-vitro diagnostics market, by country, 2018-2024 (USD Million)

TABLE 16.    Industry impact forces

TABLE 17.    Reagents & kits market size, by country, 2013 – 2017 (USD Million)

TABLE 18.    Reagents & kits market size, by country, 2018 – 2024 (USD Million)

TABLE 19.    Instruments market size, by country, 2013 – 2017 (USD Million)

TABLE 20.    Instruments market size, by country, 2018 – 2024 (USD Million)

TABLE 21.    Data management software market size, by country, 2013 – 2017 (USD Million)

TABLE 22.    Data management software market size, by country, 2018 – 2024 (USD Million)

TABLE 23.    Services market size, by country, 2013 – 2017 (USD Million)

TABLE 24.    Services market size, by country, 2018 – 2024 (USD Million)

TABLE 25.    Clinical chemistry market size, by country, 2013 – 2017 (USD Million)

TABLE 26.    Clinical chemistry market size, by country, 2018 – 2024 (USD Million)

TABLE 27.    Immunoassay/immunochemistry market size, by country, 2013 – 2017 (USD Million)

TABLE 28.    Immunoassay/immunochemistry market size, by country, 2018 – 2024 (USD Million)

TABLE 29.    Molecular diagnostics market size, by country, 2013 – 2017 (USD Million)

TABLE 30.    Molecular diagnostics market size, by country, 2018 – 2024 (USD Million)

TABLE 31.    Hematology market size, by country, 2013 – 2017 (USD Million)

TABLE 32.    Hematology market size, by country, 2018 – 2024 (USD Million)

TABLE 33.    Microbiology market size, by country, 2013 – 2017 (USD Million)

TABLE 34.    Microbiology market size, by country, 2018 – 2024 (USD Million)

TABLE 35.    Coagulation & Haemostasis market size, by country, 2013 – 2017 (USD Million)

TABLE 36.    Coagulation & Haemostasis market size, by country, 2018 – 2024 (USD Million)

TABLE 37.    Urinalysis market size, by country, 2013 – 2017 (USD Million)

TABLE 38.    Urinalysis market size, by country, 2018 – 2024 (USD Million)

TABLE 39.    Others market size, by country, 2013 – 2017 (USD Million)

TABLE 40.    Others market size, by country, 2018 – 2024 (USD Million)

TABLE 41.    Oncology market size, by country, 2013 – 2017 (USD Million)

TABLE 42.    Oncology market size, by country, 2018 – 2024 (USD Million)

TABLE 43.    Infectious diseases market size, by country, 2013 – 2017 (USD Million)

TABLE 44.    Infectious diseases market size, by country, 2018 – 2024 (USD Million)

TABLE 45.    Diabetes market size, by country, 2013 – 2017 (USD Million)

TABLE 46.    Diabetes market size, by country, 2018 – 2024 (USD Million)

TABLE 47.    Cardiology market size, by country, 2013 – 2017(USD Million)

TABLE 48.    Cardiology market size, by country, 2018 – 2024 (USD Million)

TABLE 49.    Nephrology market size, by country, 2013 – 2017 (USD Million)

TABLE 50.    Nephrology market size, by country, 2018 – 2024 (USD Million)

TABLE 51.    Autoimmune diseases market size, by country, 2013 – 2017 (USD Million)

TABLE 52.    Autoimmune diseases market size, by country, 2018 – 2024 (USD Million)

TABLE 53.    Drug testing/pharmacogenomics market size, by country, 2013 – 2017 (USD Million)

TABLE 54.    Drug testing/pharmacogenomics market size, by country, 2018 – 2024 (USD Million)

TABLE 55.    Others market size, by country, 2013 – 2017 (USD Million)

TABLE 56.    Others market size, by country, 2018 – 2024 (USD Million)

TABLE 57.    Hospitals market size, by country, 2013 – 2017 (USD Million)

TABLE 58.    Hospitals market size, by country, 2018 – 2024 (USD Million)

TABLE 59.    Point of care testing market size, by country, 2013 – 2017 (USD Million)

TABLE 60.    Point of care testing market size, by country, 2018 – 2024 (USD Million)

TABLE 61.    Laboratories market size, by country, 2013 – 2017 (USD Million)

TABLE 62.    Laboratories market size, by country, 2018 – 2024 (USD Million)

TABLE 63.    Academic institutes market size, by country, 2013 – 2017 (USD Million)

TABLE 64.    Academic institutes market size, by country, 2018 – 2024 (USD Million)

TABLE 65.    Others market size, by country, 2013 – 2017 (USD Million)

TABLE 66.    Others market size, by country, 2018 – 2024 (USD Million)

TABLE 67.    North America in-vitro diagnostics market size, by country, 2013-2017(USD Million)

TABLE 68.    North America in-vitro diagnostics market size, by country, 2018-2024 (USD Million)

TABLE 69.    North America in-vitro diagnostics market size, by product type, 2013-2017, (USD Million)

TABLE 70.    North America in-vitro diagnostics market size, by product type, 2018-2024, (USD Million)

TABLE 71.    North America in-vitro diagnostics market size, by services type, 2013-2017, (USD Million)

TABLE 72.    North America in-vitro diagnostics market size, by service type, 2018-2024, (USD Million)

TABLE 73.    North America in-vitro diagnostics market size, by technology, 2013-2017, (USD Million)

TABLE 74.    North America in-vitro diagnostics market size, by technology, 2018-2024, (USD Million)

TABLE 75.    North America in-vitro diagnostics market size, by application, 2013-2017, (USD Million)

TABLE 76.    North America in-vitro diagnostics market size, by application, 2018-2024, (USD Million)

TABLE 77.    North America in-vitro diagnostics market size, by end-use, 2013-2017, (USD Million)

TABLE 78.    North America in-vitro diagnostics market size, by end-use, 2018-2024, (USD Million)

TABLE 79.    U.S. in-vitro diagnostics market size, by product type, 2013-2017, (USD Million)

TABLE 80.    U.S. in-vitro diagnostics market size, by product type, 2018-2024, (USD Million)

TABLE 81.    U.S. North America in-vitro diagnostics market size, by services type, 2013-2024, (USD Million)

TABLE 82.    U.S. in-vitro diagnostics market size, by service type, 2018-2024, (USD Million)

TABLE 83.    U.S. in-vitro diagnostics market size, by technology, 2013-2017, (USD Million)

TABLE 84.    U.S. in-vitro diagnostics market size, by technology, 2018-2024, (USD Million)

TABLE 85.    U.S. in-vitro diagnostics market size, by application, 2013-2017, (USD Million)

TABLE 86.    U.S. in-vitro diagnostics market size, by application, 2018-2024, (USD Million)

TABLE 87.    U.S. in-vitro diagnostics market size, by end-user, 2013-2017, (USD Million)

TABLE 88.    U.S. in-vitro diagnostics market size, by end-user, 2018-2024, (USD Million)

TABLE 89.    Canada in-vitro diagnostics market size, by product type, 2013-2017, (USD Million)

TABLE 90.    Canada in-vitro diagnostics market size, by product type, 2018-2024, (USD Million)

TABLE 91.    Canada in-vitro diagnostics market size, by services type, 2013-2024, (USD Million)

TABLE 92.    Canada in-vitro diagnostics market size, by service type, 2018-2024, (USD Million)

TABLE 93.    Canada in-vitro diagnostics market size, by technology, 2013-2017, (USD Million)

TABLE 94.    Canada in-vitro diagnostics market size, by technology, 2018-2024, (USD Million)

TABLE 95.    Canada in-vitro diagnostics market size, by application, 2013-2017, (USD Million)

TABLE 96.    Canada in-vitro diagnostics market size, by application, 2018-2024, (USD Million)

TABLE 97.    Canada in-vitro diagnostics market size, by end-user, 2013-2017, (USD Million)

TABLE 98.    Canada in-vitro diagnostics market size, by end-user, 2018-2024, (USD Million)
 

CHARTS & FIGURES

FIG 1.    Industry segmentation

FIG 2.    North America in-vitro diagnostics market, 2013 - 2024 (USD Million)

FIG 3.    Growth potential analysis, by product type

FIG 4.    Growth potential analysis, by service type

FIG 5.    Growth potential analysis, by technology

FIG 6.    Growth potential analysis, by application

FIG 7.    Growth potential analysis, by end-user

FIG 8.    Porter’s analysis

FIG 9.    Company market share analysis, 2017

FIG 10.    Strategy dashboard

FIG 11.    PESTEL analysis


Select License

North America In-vitro Diagnostics Market Growth Analysis Report 2024


Related Reports
Why Choose us?
  • On-Time Delivery
  • Assured Quality
  • Industry Experts
  • Payment Security
Share Social-media